Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 200 across all filing types
Latest filing 2023-03-30 Declaration of Voting R…
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides the official outcomes of the shareholder votes held on 2023-03-30, including the approval of financial statements and director remuneration. This falls directly under the category of Declaration of Voting Results.
2023-03-30 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of financial data, audit opinions, and key financial metrics for the fiscal year. While it contains financial data, it is a standardized regulatory disclosure form used to announce the receipt and filing of the audit report rather than the full, multi-page audited financial statement document itself. Therefore, it falls under the category of a regulatory filing. FY 2022
2023-03-22 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 23rd fiscal year (2022) of DreamCIS, a South Korean company. It contains detailed information on company overview, history, capital changes, and business operations. In the context of Korean financial filings, the '사업보고서' is the equivalent of the US 10-K annual report, as it is the comprehensive annual disclosure document submitted to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2022
2023-03-22 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고). It contains detailed financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement) for the fiscal year 2022, which are typically included as part of the proxy materials or meeting agenda materials for an Annual General Meeting (AGM). Since the document is a formal filing related to the AGM agenda and includes the financial statements to be approved at that meeting, it is classified as AGM Information.
2023-03-22 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for DreamCIS. It outlines the date, time, location, and agenda items (such as approval of financial statements and director compensation). This type of document is a standard proxy solicitation or notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2023-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted by DreamCIS regarding the scheduling of their Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the reasons for this scheduling conflict due to audit and reporting timelines. As this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2023-03-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.